• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Investing

Intuitive Surgical stock sinks despite earnings beat on 2026 procedure growth outlook

by July 17, 2026
written by July 17, 2026

Intuitive Surgical shares fell about 12% in premarket trading on Friday.

The decline came after the robotic surgery company issued a full-year procedure growth forecast that disappointed investors.

The weak outlook overshadowed stronger-than-expected second-quarter earnings and revenue.

The maker of the da Vinci robotic surgery platform reported adjusted earnings of $2.80 per share for the quarter, comfortably ahead of analysts’ estimates of $2.51.

Revenue rose 19% year over year to $2.89 billion, beating Wall Street expectations of $2.82 billion.

Despite the earnings beat, investors focused on management’s projection that da Vinci procedure growth for 2026 will range between 13.5% and 15.5%, with growth expected to be near the midpoint of 14.5%.

Strong quarter overshadowed by conservative procedure growth outlook

The company continued to benefit from the growing adoption of its robotic-assisted surgery platforms.

Worldwide procedures performed using the company’s da Vinci and Ion systems increased by about 16% during the quarter.

Da Vinci procedures rose approximately 15%, while procedures using the Ion endoluminal system surged 36%.

Intuitive placed 468 da Vinci surgical systems during the quarter, compared with 395 in the same period last year.

The figure included 246 installations of its latest da Vinci 5 platform.

The company’s installed base also continued to expand.

As of June 30, Intuitive had 11,710 da Vinci systems installed globally, up 12% from a year earlier.

The installed base for Ion systems grew 21% to 1,096 units.

Revenue from instruments and accessories, which represents the company’s largest and most recurring business, climbed 18% to $1.73 billion.

Systems revenue increased to $685 million from $575 million a year ago.

The company also benefited from a one-time tariff-related refund worth $28 million after tax, equivalent to $0.08 per share.

Management expects adjusted gross margins of between 68% and 69% of revenue for 2026, an improvement from its earlier guidance of 67.5% to 68.5%.

The forecast includes an estimated one percentage point impact from tariffs.

The company also projected adjusted operating expense growth of 11% to 13%.

However, market attention centered on the procedure growth outlook, which many investors viewed as conservative given the company’s premium valuation and long history of double-digit expansion.

The results also come shortly after hospital operator HCA Healthcare warned about softer surgical procedure demand and a rise in uninsured patients following the expiration of pandemic-era Affordable Care Act subsidies.

Analysts remain optimistic despite concerns

ISRG shares have declined about 29% this year, reflecting concerns over slowing growth, increasing competition, and premium valuations.

TD Cowen recently lowered its price target on the stock to $520 from $585 while maintaining a Buy rating.

The brokerage cited competitive pressures, remanufactured surgical instruments, international market challenges, and valuation concerns as factors weighing on sentiment.

Even after lowering its target, TD Cowen’s revised valuation still implies roughly 29% upside from Thursday’s closing price.

Stifel has maintained a more optimistic stance.

The brokerage reiterated its Buy rating and $670 price target following a survey of 100 robotic surgeons across multiple specialties.

The survey suggested surgeons continue to view Intuitive’s technology leadership favourably despite the emergence of new competitors in robotic surgery.

According to Stifel, recently announced upgrades to the da Vinci 5 platform further strengthen the company’s competitive position.

The US robotic surgery market is entering its first significant competitive phase in more than two decades after Intuitive largely dominated the segment.

Valuation debate continues

Some market commentators believe the recent sell-off has made the stock more attractive.

The Motley Fool’s James Halley noted that Intuitive’s forward price-to-earnings multiple has fallen to around 36 times, well below its five-year average of more than 58 times.

“This compression offers a much more attractive entry point into a company where more than 80% of revenue is highly durable and recurring, from instruments, accessories, and services,” Halley said.

Wall Street remains broadly positive on the company despite the recent weakness.

According to analyst estimates, the average price target has moderated from $556.89 to $521.37, with forecasts ranging from $366 to $750 per share.

Based on Wednesday’s closing price, the consensus target still implies approximately 30% upside.

Among 35 analysts covering the stock, 24 recommend buying Intuitive Surgical, while 10 rate it a Hold and only one recommends selling, indicating that most analysts continue to view the current weakness as a short-term setback rather than a deterioration in the company’s long-term growth prospects.

The post Intuitive Surgical stock sinks despite earnings beat on 2026 procedure growth outlook appeared first on Invezz

0 comment
0
FacebookTwitterPinterestEmail

previous post
Kimi K3 explained: Inside Moonshot’s biggest open AI bet yet
next post
Volvo Group reports higher Q2 earnings, lifts truck market outlook

related articles

Nvidia stock rises after hours as revenue forecast...

November 17, 2026

Why this analyst sees a 30% upside for...

November 17, 2026

Netflix stock analysis: what next for this fallen...

November 17, 2026

Evening digest: Huang says he is prepared to...

November 17, 2026

Salesforce stock slides as technology outages rattle software...

November 17, 2026

Micron stock falls 2%, why this analyst cut...

November 17, 2026

Nebius stock is falling: Here’s why NBIS may...

November 17, 2026

Nike outlines $5B growth plan as turnaround faces...

November 17, 2026

Jensen Huang keeps door open to return as...

November 17, 2026

Why SpaceX stock is rising on Tuesday?

November 17, 2026
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Best small-cap stocks to buy as market rally broadens

    June 26, 2026
  • Bank of America stock in focus after CEO warns of slower Q3 revenue growth

    September 15, 2026
  • Is Europe’s stock market finally shedding its value-trap label?

    September 10, 2026
  • Why is Meta stock down on Thursday despite analysts raising PTs post Meta Connect?

    September 24, 2026
  • Blue state in hot seat for taking more than 2 years to remove criminal illegal alien from voter roll

    June 22, 2026

Popular Posts

  • 1

    Why SpaceX stock is down around 3% on Tuesday

    September 15, 2026
  • 2

    Micron stock falls 4%, why this analyst sees 40% upside for the stock?

    September 28, 2026
  • 3

    Evening digest: US jobs cool, gold falls as Treasury yields rise

    October 2, 2026
  • 4

    Intel, AMD stocks slide again in aftermath of Broadcom’s weak outlook

    June 5, 2026
  • 5

    Nike stock sinks after earnings as its comeback plan turns into more layoffs

    October 2, 2026

Categories

  • Editor's Pick (711)
  • Investing (2,601)
  • Stock (90)

Latest Posts

  • Nikkei falls as Broadcom-triggered AI fears hammer Asian chip stocks

    June 5, 2026
  • Tlaib moves to block ICE airport arrests, says TSA helping target immigrants

    August 5, 2026
  • Trump spares no one at WHCA dinner, taking aim at Dems, press and his own Cabinet

    July 25, 2026

Recent Posts

  • Dem running for Pelosi’s seat mocked after anti-Israel hecklers chase him from SF Trans March

    June 29, 2026
  • Why is IREN stock up 5% in premarket trading on Monday?

    October 12, 2026
  • Starbucks stock falls as it reportedly explores a Chipotle takeover deal

    October 8, 2026

Editor’s Pick

  • MEXC CEO warns users against over-sharing with AI

    November 4, 2026
  • Socialist tenant organizer who blasted ‘sell-out Democrats’ loses Midwest primary

    August 5, 2026
  • Mamdani official’s planned meeting with Iran envoy shut down by State Department

    July 10, 2026
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock